Investigating the effect of pyridostigmine in individuals with poor ovarian response
Phase 3
Recruiting
- Conditions
- Infertility.Female infertility
- Registration Number
- IRCT20100518003950N8
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 110
Inclusion Criteria
Women with a history of poor response to ovarian stimulation in previous cycles who are willing to undergo a new cycle.
Exclusion Criteria
BMI more than 30
Respiratory diseases (such as asthma, COPD), renal disease, slow or irregular heartbeat, a history of slow bowel movements and constipation (due to the possibility of delayed drug metabolism), or metabolic disorders.
Taking any other cholinergic drug.
Endometriosis, stage III-IV
History of allergic reactions
Taking psychotropic medications and corticosteroids
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retrieved Oocytes. Timepoint: 36 hours after receiving the ovulation induction. Method of measurement: Laboratory count.
- Secondary Outcome Measures
Name Time Method